Form CORRESP - Correspondence:
SEC Accession No. 0001493152-20-000935
Filing Date
2020-01-22
Accepted
2020-01-22 18:21:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 22682
2 logo_001.jpg GRAPHIC 4595
  Complete submission text file 0001493152-20-000935.txt   30314
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 7389 Services-Business Services, NEC